申请人:Abbott Laboratories
公开号:US05472958A1
公开(公告)日:1995-12-05
Selective and potent cholinergic ligands selective for neuronal nicotinic cholinergic channel receptors, which ligands have the formula: ##STR1## as well as pharmaceutically-acceptable salts or prodrugs thereof, which are useful in the treatment of dementias, attentional hyperactivity disorder, or substance abuse withdrawal characterized by decreased cholinergic function, one of which is also an analgesic agent, and one of which is an agent useful for treating anxiety associated with cognitive impairment.
具有以下结构式的选择性和有效的胆碱能配体,这些配体选择性地作用于神经尼古丁胆碱通道受体,以及其药用盐或前药,这些配体在治疗痴呆、注意力过度活跃障碍或物质滥用戒断中具有降低胆碱功能的特征方面具有用处,其中一个还是镇痛剂,另一个是用于治疗与认知障碍相关的焦虑的药物。